PHASE 2B TRIAL TO EVALUATE THE SAFETY AND FACTOR IX LEVELS RESULTING FROM A DAILY SUBCUTANEOUS PROPHYLAXIS TREATMENT REGIMEN OF DALCINONACOG ALFA (DALCA) IN HEMOPHILIA BJ. Mahlangu,H. Levy,C. Negrier,M. Fretigny,F. Del Greco,L. Neuman,G. BlouseHAEMOPHILIA（2020）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
